about
Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis.Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.Bone remodelling markers in rheumatoid arthritis.Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone lossEffects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureExposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature.IL-7 and lymphopenia.Potential role of arthroscopy in the management of inflammatory arthritis.Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health.Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).Expression of the calcium-sensing receptor in monocytes from synovial fluid is increased in osteoarthritis.[Post-surgical septic arthritis of the pubic symphysis].[A rare cause of back pain and fever].Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis: experience from an immunotherapy unit of rheumatology.Decrease of Tocilizumab Dose in Patients with Rheumatoid Arthritis: A Pilot Study.Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.Biomarkers in rheumatoid arthritis.No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis.Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.Atypical forms of syphilis: two cases.Leflunomide-induced subacute cutaneous lupus erythematosus.Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.A relapsing macrodactyly.Lupus revealing itself after a stiff-person syndrome.Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient.Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study.Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.Clinical interest of autoantibodies directed against citrullinated peptides in Indian patients with rheumatoid arthritis.Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.Treatment of primary Sjögren syndrome with rituximab: a randomized trial.Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study.Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?Early inflammatory clinics. Experience with early arthritis/back pain clinics.Paradoxical appearance of adult scurvy in Martinique, French West Indies.Reliability of histopathological salivary gland biopsy assessment in Sjogren's syndrome: a multicentre cohort studyEuropean League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients
P50
Q24812290-F8EF39BA-9A6E-4662-8566-70FEDCB8B1F1Q30948155-BFC8C2AA-50F8-43BD-90CB-A41CCBC5DB90Q33563068-FF3AD2FF-3CE6-46C1-A0F3-AA80F7DCD457Q34440102-47AD6774-28C6-4BBC-8DB1-19444947879FQ34663199-D38827E1-1018-4A9D-B962-155058A450B2Q34743817-7CBC9355-A0F4-492F-83FF-9604CEC18D24Q35774612-589E9A77-CA65-4809-BBD9-DC9EACEB60A9Q36070691-7F9C3E25-4F6B-4708-910C-D3ED325B362FQ36481706-1910628D-5CC0-46F7-B458-DA1F7E035708Q37342365-24A6EF08-9A6C-46D3-A179-54FE57C9DDC5Q37789936-0227F8DF-0913-4A45-A249-A6B8D68CB14EQ38021852-B4984E24-1964-42C7-8916-6EFE6EE04B05Q38157393-BF9958F7-3953-496D-A9F0-1ABA80147F78Q39081726-812659C8-98CD-4A7E-98E0-BCEFB4772819Q39653702-4EEA52FC-F632-4773-A19A-B2E1634BDCD5Q40172788-E90742A5-AE32-4FAA-8DCD-405FB32B99EFQ40178521-9A67EE09-488F-4A08-BA50-DBCEC282ACEEQ40477415-9E935148-0BFD-4714-BF94-57A69D150CC8Q40699045-6252E3AE-A413-4D6C-9A1A-72AB7AD26C5CQ40788189-9F7A1D04-5D9B-427B-A3EE-A352005B0B3EQ41849728-68D6D028-F94A-49B0-BEA3-97AECD090440Q41966638-611C0743-0BF1-4FED-8196-59FADDD6EC8CQ44343787-639708D1-EB82-4F58-9DF9-BD77DFDB0771Q46086989-1B9393A9-A254-42AA-AD8B-CA4E551B1B96Q46367693-FF03F1D3-ACA9-4A58-9E4E-1F94DFEF9583Q46555455-1FF27AB6-06B3-4CC3-9441-688B90C08DF5Q47657337-4EBE1401-1774-4D36-B49F-355E4451820AQ47669154-AB25F2D0-A324-473A-BDD9-CC49F9A6B668Q47740256-9F41B813-B266-48F3-A251-1214E1FD3828Q47938362-00682A77-255D-4AF3-B847-226FB8B80563Q47970691-BA70464D-D829-421F-B37E-A2E87AC1CBEFQ48023812-D615C813-F073-4B21-BCAD-02528B067BEDQ48568061-39DB300A-A077-4A1A-8897-6A33D8C389CAQ50698948-8E7A0D97-9B10-4DC0-8B9B-72EA6D203511Q50772450-69C56BB0-C00D-4F63-AC79-105CCD15A0A7Q52847768-903273E8-1588-4915-AAF0-FC7D2513E368Q52848276-93429705-93A2-445E-90A4-5E545B1D0CF2Q53317444-4D454730-57A2-4C0E-A48E-779EFD849058Q57612757-C3DAD897-EAFE-456B-80FD-0B557C644189Q57612823-A69642CF-96A3-4F23-93C4-5FBD09B5D626
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vincent Goeb
@ast
Vincent Goeb
@en
Vincent Goeb
@es
Vincent Goeb
@nl
type
label
Vincent Goeb
@ast
Vincent Goeb
@en
Vincent Goeb
@es
Vincent Goeb
@nl
prefLabel
Vincent Goeb
@ast
Vincent Goeb
@en
Vincent Goeb
@es
Vincent Goeb
@nl
P106
P31
P496
0000-0002-3807-545X